[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353930-105":59,"doc-detail-353930-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","recruitment-of-brd4-to-the-asxl1-genomic-targets-depends-on-the-extra-terminal-domain-of-brd4","Recruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4","","ASXL1 is a cancer-driving factor whose transcriptional association with BRD4 is investigated through genetic, structural, and biochemical analyses. The study finds a tight complex formed by the BRD4 extra-terminal domain and an ASXL1 BRD4-binding motif, and shows that BRD4 recruitment to ASXL1 genomic targets requires this interaction, supported by ChIP-seq of BRD4-binding–defective ASXL1 mutants. Truncated ASXL1 variants retain BRD4 binding, with ASXL1 1-645 enhanced promoter recruitment and a distinct co-interaction with MLL3/4, suggesting a feedforward regulatory mechanism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recruitment-of-brd4-to-the-asxl1-genomic-targets-depends-on-the-extra-terminal-domain-of-brd4/353930/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recruitment-of-brd4-to-the-asxl1-genomic-targets-depends-on-the-extra-terminal-domain-of-brd4/353930.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about how BRD4 is recruited to ASXL1 genomic targets?","Question",{"text":112,"@type":113},"BRD4 recruitment to ASXL1 targets depends on an interaction between the BRD4 extra-terminal domain and an ASXL1 BRD4-binding motif, supported by ChIP-seq using ASXL1 mutants that cannot bind BRD4.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which ASXL1 regions are implicated in BRD4 binding and promoter recruitment?",{"text":117,"@type":113},"Cancer-related truncated ASXL1 variants comprising residues 1-645 and 1-591 retain BRD4 binding. The 1-645 variant shows enhanced ability to recruit BRD4 to promoters of ASXL1 target genes.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the ASXL1 variants differ in interaction partners?",{"text":121,"@type":113},"ASXL1 1-645 can independently interact with BRD4 and the H3K4-specific methyltransferases MLL3/4, while the shorter ASXL1 1-591 lacks the MLL3/4-binding site and interacts only with BRD4.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353930,1790628669,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article [https://doi.org/10.1038/s41467-026-69565-z](https://doi.org/10.1038/s41467-026-69565-z)  \nRecruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4  \nReceived: 10 July 2025  \n\n| Accepted: 28 January 2026 |\n| --- |\n| |\n| Check for updates |\n\nKarthik Selvam 1, Shuang Lu2,3, Clémence Messmer4, Yakun Pang5, Soumi Biswas1, Moustafa Khalil4, Peng Zhang 5, Rima Tulaiha6, Ming-Ming Zhou 7, Toshio Kitamura 8, Shannon M. Lauberth 6,  \nM. Andres Blanco 9, Feng-Chun Yang 5, El Bachir Affar 4,10, Zibo Zhao 6, Lei Zeng 2,3 , Lu Wang 6  & Tatiana G. Kutateladze 1   \nASXL1is a well-established driver of a wide range of cancers. Here, we identify a high level of genetic correlation between ASXL1 and the major transcriptional activator BRD4 in cancer cells and characterize the molecular mechanism underlying this correlation. Structural and biochemical data show the formation of a tight complex between the extraterminal domain of BRD4 and the BRD4-binding motif of ASXL1. ChIP-seq analysis of mutated ASXL1 that cannot bind BRD4 demonstrates that the recruitment of BRD4 to the ASXL1 genomic targets depends on this interaction. We ﬁnd that the cancer-related truncated variants comprising residues1-645and1-591ofASXL1(ASXL11-645 and ASXL11-591) retain BRD4 binding function, with ASXL11-645 showing an enhanced ability to recruit BRD4 to promoters of ASXL1 target genes. In contrast to ASXL11-591, ASXL11-645 simultaneously and independently interacts with BRD4 and the H3K4-speciﬁc methyltransferases MLL3/4, whereas the shorter variant is lacking the MLL3/4-binding site and interacts only with BRD4. Genomic data from six cancer types reveals a strong positive ASXL1-BRD4 relationship, with BRD4 occupying the ASXL1 promoter and thus pointing to a possible feedforward mechanism. Our ﬁndings provide mechanistic details by which ASXL1 associates with BRD4 and shed light on the biological signiﬁcance of this  \nassociation.  \nThe transcriptional coregulator and a core component of the Polycomb Repressive Deubiquitinase(PR-DUB)complex, ASXL1(additional sex combs like 1), is frequently mutated and truncated in human malignances, particularly in acute and chronic myeloid leukemias (AML and CML, respectively) and myelodysplastic syndromes (MDS)1–7 (Fig. 1a). ASXL1 stimulates activity of the catalytic subunit of the PRDUB complex, the ubiquitin hydrolase BAP1, that deubiquitinates mono-ubiquitinated lysine 119 of histone H2A, a mark of repressive chromatin deposited by the Polycomb repressive complex-1 (PRC1) to maintain Polycomb group (PcG) target gene silencing and preserve  \ncellular transcriptional identity5,8,9. Additionally, ASXL1was reported to associate with components of the H3K27me3-speciﬁc PRC2 complex, nuclear hormone receptors, BRD4and MLL3/4and therefore functions as a context-speciﬁcgene regulator7,10. ASXL1 and its homologs ASXL2 and ASXL3 share a common domain architecture of a HARE-HTH domain, the BAP1-binding DEUBAD domain, the MLL3/4 binding helix (MBH) and a C-terminal zinc ﬁnger (Fig. 1b).  \nLike ASXL1, the transcriptional co-activator bromodomain and extra-terminal domain 4 (BRD4) is also linked to tumorigenesis. It forms chromosomal translocations in squamous carcinoma and NUT  \nA full list of afﬁliations appears at the end of the paper. e-mail: leizeng@j[lu.edu.cn](lu.edu.cn); [lu.wang1@northwestern.edu](lu.wang1@northwestern.edu); [tatiana.kutateladze@cuanschutz.edu](tatiana.kutateladze@cuanschutz.edu)  \nmidline carcinoma, plays a role in the progression of AML, and is upregulated in breast cancer11–17. BRD4 contains two acetyllysinebinding bromodomains with distinct functions (Fig. 1b). The ﬁrst bromodomain (BD1) binds to poly-acetylated histones, such as H4K5acK8ac, whereas the second bromodomain (BD2) selects for acetylated non-histone proteins18–20. The extra-terminal(ET) domain of BRD4 recognizes the hKhKh motif (where h is a hydrophobic residue) found in LANA, CHD4, BRG1, integrase, and NSD","cbCaieH3CWwqU3A5","https://ap.wps.com/l/cbCaieH3CWwqU3A5","pdf",3915911,16,"English","# Abstract\n## Molecular complex formation and binding requirements\n## ASXL1 truncated variants and MLL3/4 interaction\n## Genomic correlation and feedforward mechanism\n## Study design and ChIP-seq/Mass spectrometry overview","[{\"question\":\"What is the main finding about how BRD4 is recruited to ASXL1 genomic targets?\",\"answer\":\"BRD4 recruitment to ASXL1 targets depends on an interaction between the BRD4 extra-terminal domain and an ASXL1 BRD4-binding motif, supported by ChIP-seq using ASXL1 mutants that cannot bind BRD4.\"},{\"question\":\"Which ASXL1 regions are implicated in BRD4 binding and promoter recruitment?\",\"answer\":\"Cancer-related truncated ASXL1 variants comprising residues 1-645 and 1-591 retain BRD4 binding. The 1-645 variant shows enhanced ability to recruit BRD4 to promoters of ASXL1 target genes.\"},{\"question\":\"How do the ASXL1 variants differ in interaction partners?\",\"answer\":\"ASXL1 1-645 can independently interact with BRD4 and the H3K4-specific methyltransferases MLL3/4, while the shorter ASXL1 1-591 lacks the MLL3/4-binding site and interacts only with BRD4.\"}]","Recruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4 | PDF",1790107995,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd16a0b514795166d06e7248fcc78566.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/041c499ae5bfc1538775b25f4b3595c2.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6436c18753371cbdf2731817c75333f0.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4a637fcb09412a7c591fa5337d105d5.webp",980,1301]